Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amicus Repositions With A Focus On Combining Chaperones With ERTs

Nov 21 2013

Related Content

Sanofi Claims Genzyme With $20.1 Billion Upfront And CVRs

Feb 21 2011

Going Deeper Into Rare Disease, GSK Takes Reins of Amicus Fabry Program

Oct 29 2010

Related Companies

GSK plc

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc.

Sanofi Genzyme

Sanofi

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Business Strategies Deals Innovation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window